Brean

Trevena Inc (NASDAQ:TRVN)'s stock had its “buy” rating reaffirmed by Brean Capital in a report released on Tuesday, Analyst Ratings Network.com reports. A number of other research analysts have also commented on the company. Cowen and Company ...

LeMaitre Vascular Inc (NASDAQ:LMAT)'s stock had its “buy” rating reissued by analysts at Brean Capital in a research report issued to clients and investors on Tuesday, Analyst Ratings Network.com reports. In other LeMaitre Vascular news, Director David B.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)'s stock had its “buy” rating reiterated by analysts at Brean Capital in a report issued on Tuesday, MarketBeat reports. Merrimack Pharmaceuticals (NASDAQ:MACK) traded down 8.65% on Tuesday, hitting ...

Aerie Pharmaceuticals Inc (NASDAQ:AERI)'s stock had its “buy” rating reaffirmed by equities researchers at Brean Capital in a note issued to investors on Tuesday, AnalystRatings.Net reports. Aerie Pharmaceuticals (NASDAQ:AERI) traded down 0.12% ...

Apple (AAPL) supplier Cavium (CAVM) is a buy, while Wal-Mart (WMT) was initiated with an underperform rating Tuesday. Cavium, which designs chips for Apple products like the iPhone, was started with a buy rating and 67 price target at Brean Capital.

Cavium Inc with TICKER NASDAQ:CAVM has had its stock rating noted as 'Initiated' with the recommendation being set at 'BUY' today by research analysts at Brean Capital. Cavium Inc are listed in the Technology sector within NASDAQ. Brean Capital have ...